Kinsler, VA;    O'Hare, P;    Jacques, T;    Hargrave, D;    Slater, O;      (2017)    MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children.                   British Journal of Cancer        10.1038/bjc.2017.49 <https://doi.org/10.1038/bjc.2017.49>.    (In press).    Green open access